Table of Content

1. Executive Summary
   1.1. Europe Precision Diagnostics Market Snapshot, 2024 and 2031
   1.2. Market Opportunity Assessment, 2024 – 2031, US$ Bn
   1.3. Key Market Trends
   1.4. Future Market Projections
   1.5. Premium Market Insights
   1.6. Industry Developments and Key Market Events
   1.7. PMR Analysis and Recommendations
2. Market Overview
   2.1. Market Scope and Definition
   2.2. Market Dynamics
       2.2.1. Drivers
       2.2.2. Restraints
       2.2.3. Opportunity
       2.2.4. Challenges
       2.2.5. Key Trends
   2.3. Macro-Economic Factors
       2.3.1. Global Sectorial Outlook
       2.3.2. Global GDP Growth Outlook
   2.4. COVID-19 Impact Analysis
   2.5. Forecast Factors – Relevance and Impact
3. Value Added Insights
   3.1. Product Adoption Analysis
   3.2. Value Chain Analysis
   3.3. Key Deals and Mergers
   3.4. PESTLE Analysis
   3.5. Porter’s Five Force Analysis
4. Price Trend Analysis, 2019 – 2031
   4.1. Key Highlights
   4.2. Key Factors Impacting Product Prices
   4.3. Pricing Analysis, By Type
5. Europe Precision Diagnostics Market Outlook: Historical (2019 – 2023) and Forecast (2024 – 2031)
   5.1. Key Highlights
       5.1.1. Market Size (US$ Bn) and Y-o-Y Growth
       5.1.2. Absolute $ Opportunity
   5.2. Market Size (US$ Bn) Analysis and Forecast
       5.2.1. Historical Market Size (US$ Bn) Analysis, 2019-2022
       5.2.2. Current Market Size (US$ Bn) Analysis and Forecast, 2023–2031
   5.3. Europe Precision Diagnostics Market Outlook: Type
       5.3.1. Introduction / Key Findings
       5.3.2. Historical Market Size (US$ Bn) Analysis, By Type, 2019 – 2023
       5.3.3. Current Market Size (US$ Bn) Analysis and Forecast, By Type, 2024 – 2031
           5.3.3.1. Genetic Tests
           5.3.3.2. Direct to Consumer Tests
           5.3.3.3. Esoteric Tests
   5.4. Market Attractiveness Analysis: Type
   5.5. Europe Precision Diagnostics Market Outlook: Application
       5.5.1. Introduction / Key Findings
       5.5.2. Historical Market Size (US$ Bn) Analysis, By Application, 2019 – 2023
       5.5.3. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2024 – 2031
           5.5.3.1. Oncology
           5.5.3.2. Respiratory Diseases
           5.5.3.3. Skin Diseases
           5.5.3.4. CNS Disorders
   5.6. Market Attractiveness Analysis: Application
   5.7. Europe Precision Diagnostics Market Outlook: End Use
       5.7.1. Introduction / Key Findings
       5.7.2. Historical Market Size (US$ Bn) Analysis, By End Use, 2019 – 2023
       5.7.3. Current Market Size (US$ Bn) Analysis and Forecast, By End Use, 2024 – 2031
           5.7.3.1. Hospitals
           5.7.3.2. Clinical Laboratories
   5.8. Market Attractiveness Analysis: End Use
6. Europe Precision Diagnostics Market Outlook: Country
   6.1. Key Highlights
   6.2. Historical Market Size (US$ Bn) Analysis, By Country, 2019 – 2023
   6.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024 – 2031
       6.3.1. Germany
       6.3.2. France
       6.3.3. U.K.
       6.3.4. Italy
       6.3.5. Spain
       6.3.6. Russia
   6.4. Market Attractiveness Analysis: Region
7. Competition Landscape
   7.1. Market Share Analysis, 2023
   7.2. Market Structure
       7.2.1. Competition Intensity Mapping By Market
       7.2.2. Competition Dashboard
   7.3. Company Profiles (Details – Overview, Financials, Strategy, Recent Developments)
       7.3.1. Abbott Laboratories
           7.3.1.1. Overview
           7.3.1.2. Segments and Products
           7.3.1.3. Key Financials
           7.3.1.4. Market Developments
           7.3.1.5. Market Strategy
       7.3.2. F. Hoffmann-La Roche Ltd.
       7.3.3. Siemens Healthineers AG
       7.3.4. Thermo Fisher Scientific Inc.
       7.3.5. bioMérieux SA
       7.3.6. Becton, Dickinson and Company
       7.3.7. Danaher Corporation
       7.3.8. QIAGEN N.V.
       7.3.9. Hologic Inc.
       7.3.10. Agilent Technologies Inc.
8. Appendix
   8.1. Research Methodology
   8.2. Research Assumptions
   8.3. Acronyms and Abbreviations